Nancy H C Loos

4PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2023
Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice.

Nancy H C Loos, Margarida L F Martins, Daniëlle de Jong

|Sep 09, 2022
The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?

Nancy H C Loos, Jos H Beijnen, Alfred H Schinkel

Pageof 1